58 studies found for:    Open Studies | "Helicobacter Infections"
Show Display Options
Rank Status Study
21 Not yet recruiting Therapeutic Trial Comparing Triple Therapy Guided by the PCR Detection of Clarithromycin Resistance vs Empiric Concomitant Quadruple Therapy for Helicobacter Pylori Infection
Conditions: H Pylori Infection Eradication;   Antibiotics Therapeutic Strategies;   H Pylori Eradication
Interventions: Other: Quadruple concomitant therapy treatment;   Other: Triple therapy guided by the result of the molecular resistance test
22 Not yet recruiting Comparison of 7-day PPI-based Standard Triple Therapy and 10-day Bismuth Quadruple Therapy for H. Pylori Eradication
Conditions: Helicobacter Pylori Infection;   Family History of Stomach Cancer
Interventions: Drug: Standard triple therapy;   Drug: Bismuth quadruple therapy
23 Not yet recruiting High Dose Dual Therapy (HDDT) for Eradication of Helicobacter Pylori Infection
Condition: Bacterial Infection Due to Helicobacter Pylori (H. Pylori)
Interventions: Drug: Nexium 40 mg;   Drug: amoxicillin 1.5 gr;   Drug: doxycycline 200 mg;   Drug: Nexium 20 mg;   Drug: clarythromicin 500 mg;   Drug: amoxicillin 1gr
24 Recruiting Food Effect on the Eradication Rate of H. Pylori With Triple Therapy With Esomeprazole
Condition: Helicobacter Pylori Infection
Interventions: Other: Food effect;   Drug: Esomeprazole;   Drug: Amoxicillin;   Drug: Clarythromycin
25 Recruiting Comparing the Efficacy of Reverse Hybrid Therapy and Bismuth Quadruple Therapy
Condition: Helicobacter Pylori Infection
Interventions: Drug: pantoprazole+bismuth+tetra+metro;   Drug: (panto+amox+clar+metr)+(panto+amox)
26 Recruiting Personalized Treatment for Refractory H Pylori Infection
Condition: Helicobacter Pylori Infection
Interventions: Drug: rabeprazole+3 antibiotics;   Drug: rabeprazole+bismuth+2 antibiotics;   Drug: rabeprazole+amox+tetr+levo
27 Recruiting Comparison of Two Rescue Therapies for Helicobacter Pylori Infection
Condition: Helicobacter Pylori Infection
Interventions: Drug: esomeprazole+amox+levo+tetra;   Drug: esomeprazole+amox+levo
28 Recruiting Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for Rescue Treatment of Hp Infection
Condition: Helicobacter Pylori Infection
Interventions: Drug: High-dose dual therapy (rabeprazole, amoxicillin);   Drug: Bismuth-containing quadruple therapy (rabeprazole, tripotassium dicitrate bismuthate, metronidazole, tetracycline)
29 Recruiting Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for First-line Treatment of Hp Infection
Condition: Helicobacter Pylori Infection
Interventions: Drug: High-dose dual therapy (rabeprazole, amoxicillin);   Drug: Bismuth-containing quadruple therapy (rabeprazole, tripotassium dicitrate bismuthate, metronidazole, tetracycline)
30 Not yet recruiting The Effect of Miswak Chewing Sticks on the Oral Helicobacter Pylori Infection
Conditions: Caries;   Periodontitis
Intervention: Biological: Oral hygiene with Miswak
31 Recruiting Randomized Study on Efficacy of Gemifloxacin-based Regimen for Helicobacter Pylori Infection
Condition: Helicobacter Pylori Infection
Interventions: Drug: Gemifloxacin-based triple therapy;   Drug: Standard triple therapy
32 Recruiting The Diagnostic Validity of the Urea Breath Test
Condition: Helicobacter Pylori Infection
Intervention: Drug: Citric acid
33 Recruiting European Registry on the Management of Helicobacter Pylori Infection
Condition: H. Pylori Infection
Intervention:
34 Recruiting Efficacy of Acetylcysteine-containing Triple Therapy in the First Line of Helicobacter Pylori Infection
Condition: Helicobacter Pylori Infection
Interventions: Drug: N-acetylcysteine + PPI-amoxicillin-clarithromycin;   Drug: PPI-amoxicillin-clarithromycin
35 Recruiting Compare Sequential and Quadruple Therapy for the Eradication of Helicobacter Pylori in Korea
Condition: Helicobacter Pylori Infection
Interventions: Drug: Pantoprazole;   Drug: Amoxicillin;   Drug: Clarithromycin;   Drug: Metronidazole;   Drug: Tetracycline;   Drug: Bismuth
36 Unknown  Gamma-Glutamyl Transpeptidase (GGT): A Potential Diagnostic Marker for Helicobacter Pylori Infections
Condition: HELICOBACTER PYLORI INFECTIONS
Intervention:
37 Recruiting Helicobacter Pylori Eradication for Gastric Cancer Prevention in the General Population
Conditions: Gastric Cancer;   Helicobacter Pylori Infection
Intervention: Drug: 10-day bismuth-based quadruple therapy
38 Recruiting Comparison of the Eradications Rates of Sequential Therapy Versus Concomitant Therapy
Condition: Helicobacter Pylori Infection
Interventions: Drug: Sequential therapy 10 days;   Drug: Sequential therapy 14 days;   Drug: Concomitant therapy 10 days;   Drug: Concomitant therapy 14 days
39 Unknown  Difference in H. Pylori Infection Rate of EGC Patients Before and After Endoscopic Resection
Condition: Early Gastric Cancer
Intervention:
40 Recruiting Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality
Conditions: Helicobacter Pylori Infections;   Atrophic Gastritis;   Gastric Cancer
Intervention: Drug: Triple therapy

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-58) Show next page of results    Last Page
Indicates status has not been verified in more than two years